Mifepristone in children with refractory Cushing’s disease

Introduction

This study is being done to examine the effects of a medication called mifepristone in children with Cushing’s disease. This medication has been approved by the Food and Drug Administration (FDA) for use in adult patients with Cushing’s syndrome. It is not FDA approved for use in children.

The study will investigate how children’s bodies absorb and process mifepristone, how it works in children and what effect it has on the use of sugar in the body, on the child’s weight and on growth hormone. An important part of the study is to determine the proper dosing and to evaluate the side effects of mifepristone in children.

Children 6 to 17 years old will be enrolled in the study if they have had surgery for Cushing’s disease and currently have elevated cortisol levels.

To get started, please click here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: